Anda di halaman 1dari 2

TuBerculosis  Vaccine  Initiative

February  2011  

Dear  sir/madam,

On  World  Tuberculosis  Day,  TuBerculosis  Vaccine  Initiative,  in  collaboration  with  Calouste  Gulbenkian  Foun-­
dation,   Fondation   Mérieux,   Friends   of   the   Global   Fund   Europe   and   Stop   TB   Partnership,   will   organize   the    
following  meetings:

Round  table:  7KH¿JKWDJDLQVWWXEHUFXORVLVZKDW¶VQHZLQUHVHDUFK"


Symposium:  Innovative  funding  and  translation  of  discoveries  into  added  
value:  new  vaccines  for  TB

24  March  2011,  15h00-­18h00,  followed  by  a  cocktail  reception


Centre  culturel  Calouste  Gulbenkian,  51  Avenue  Iéna,  75116  Paris,    
Interpretation  EN/FR  will  be  available.

The   world   faces   tremendous   challenges   to   combat   big   health   problems,   such   as  Aids,   Tuberculosis   and    
Malaria.  Millions  of  euros  have  already  been  spent  to  develop  new  tools  to  combat  these  diseases,  which  are  
also  a  threat  for  Europe.  But  state  budgets  of  developed  countries  are  under  huge  pressure.  In  the  meantime,  
the  importance  of  innovation  on  the  agendas  of  European  countries  and  the  European  Union  is  rising  (EU  2020  
DJHQGD(XURSH)ODJVKLS,QLWLDWLYH,QQRYDWLRQ8QLRQ +RZWRKDQGOHWKLVREYLRXVFRQÀLFWRILQWHUHVWV"

On  World  Tuberculosis  Day  (24  March)  a  round  table  discussion  will  be  organized  followed  by  a  symposium  
where  the  possibilities  to  bring  all  challenges  together  will  be  discussed.  An  innovative  funding  model  will  be  
SUHVHQWHGWRDVVXUHWKHGHYHORSPHQWRIQHZWRROVWRFRPEDWGLVHDVHVDQGWRDVVXUH(XURSH¶VOHDGLQJUROHLQ
the  development  of  these  tools.  >>
Programme:  

15h00-­15h05:     Welcome  by  Dr.  Emílio  Rui  Vilar,  President  of  the  Calouste  Gulbenkian  Foundation

15h05-­16h30:     5RXQGWDEOH7KH¿JKWDJDLQVWWXEHUFXORVLVZKDW¶VQHZLQUHVHDUFK
  6SHDNHUV'U-RUJH6DPSDLR816HFUHWDU\*HQHUDO¶V6SHFLDO(QYR\WRVWRS7%
  'U3DWULFH'HEUp$PEDVVDGRUIRUWKH¿JKWDJDLQVW$,'6DQGFRPPXQLFDEOHGLVHDVHV 
    Ministry  of  foreign  and  European  affairs,  France
  'U&KULVWLDQ/LHQKDUGW6HQLRUVFLHQWL¿FDGYLVRU6WRS7%3DUWQHUVKLS

16h30-­16h45:     Coffee  break

16h45-­18h00:     6\PSRVLXP,QQRYDWLYHIXQGLQJDQGWUDQVODWLRQRIGLVFRYHULHVLQWRDGGHGYDOXH
  QHZYDFFLQHVIRU7%

K  ,QWURGXFWLRQE\'U-RUJH6DPSDLR816HFUHWDU\*HQHUDO¶V6SHFLDO(QYR\WRVWRS7%
16h50:     Ms.  Michèle  Barzach,  France,  former  Minister  of  health  and  President  of  ‘Friends  of  the      
    Global  Fund  Europe:  The  needs  of  the  world  for  innovative  ways  to  combat  Aids,  Tuberculosis    
    and  Malaria.
K  0U%HQRvW0LULEHO'LUHFWRU*HQHUDO)RQGDWLRQ0pULHX[)UDQFH¶:KLFKLQQRYDWLYHPHDVXUHV
  DUHQHHGHGWRDFWPRUHTXLFNO\DJDLQVWWXEHUFXORVLVLQWKH¿HOG"¶
17h10:     Dr.  Onno  Ruding,  chairman  of  the  Board  of  the  Centre  for  European  Policy  Studies  in      
  %UXVVHOVIRUPHUPLQLVWHURI¿QDQFHVRI7KH1HWKHUODQGVµ7%9,DVDPRGHO¶
17h20:     Dr.  Joris  Vandeputte,  TBVI:  ‘Translating  science  into  products  through  innovative  funding;;    
  GHYHORSLQJWXEHUFXORVLVYDFFLQHV¶
17h30:     Ms.  Clara  de  la  Torre,  Director  of  Research  and  Innovation  within  the  Directorate  General  of    
    Research,  representing    European  commissioner  for  research,  innovation  and  Science      
  *HRJKHJDQ4XLQQµ7KH,FRQRP\¶
K  0V)UDQoRLVH*URVVHWrWH0(3 WREHFRQ¿UPHG µ7KHUROHRIWKH(XURSHDQ3DUOLDPHQWLQ
  VWUHQJWKHQLQJDQLQQRYDWLYH(XURSH¶
K  'LVFXVVLRQPRGHUDWHGE\'U3DWULFH'HEUp$PEDVVDGRUIRUWKH¿JKWDJDLQVW$,'6DQG 
    communicable  diseases,  Ministry  of  foreign  and  European  affairs,  France
18h00:     Cocktail  reception.

:HZRXOGEHYHU\KRQRXUHGLI\RXZRXOGOLNHWRMRLQWKLVURXQGWDEOHDQGV\PSRVLXP3OHDVH¿OOLQWKH
registration  form  on  www.tbvi.eu/registration_formEHIRUH0DUFKWRFRQ¿UP

Kind  regards,

Ms.  Isabel  Mota,  Trustee  of  the  Gulbenkian  Foundation  in  Lisbon,  Portugal
Mr.  Benoît  Miribel,  Director  General  Fondation  Mérieux,  Lyon,  France
Mrs  Michèle  Barzach,  Former  Minister  of  Health,  President  of  Friends  of  the  Global  Fund  Europe,  Paris,  France
Dr  Lucica  Ditiu,  Executive  Secretary,  Stop  TB  Partnership,  Switzerland  
Dr.  Jelle  Thole,  Director  TuBerculosis  Vaccine  Initiative  (TBVI),  The  Netherlands

For  questions,  please  contact  erna.balk@tbvi.eu  

Anda mungkin juga menyukai